Cholesterol deficiency increases the vulnerability of hippocampal glia in primary culture to glutamate-induced excitotoxicity

Neurochemistry International

Volumn 43, Issue 3, 2003, Pages 197-209

  Chou, Yun Chia ^a   Lin, Shin Bey ^a   Tsai, Lien Hsin ^a   Tsai, Hung I ^a   Lin, Chiao Mei ^a  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

Cholesterol deficiency; Glutamate induced excitotoxicity; Hippocampal glia

Indexed keywords

BETA CYCLODEXTRIN; CHOLESTEROL; GLUTAMIC ACID; LACTATE DEHYDROGENASE; MEVINOLIN; THYMIDINE DERIVATIVE; TRITIUM;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ASTROCYTE; CELL ACTIVITY; CELL CYCLE; CELL DIFFERENTIATION; CELL LOSS; CELL PROLIFERATION; CELL TYPE; CELL VIABILITY; CONTROLLED STUDY; FEMALE; GLIA CELL; HIPPOCAMPUS; MEMBRANE DAMAGE; NERVE CELL; NERVE CELL CULTURE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0346037335     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-0186(03)00003-2     Document Type: Article

References (78)

1. Alberts M.J., Graffagnino C., McClenny C., DeLong D., Strittmatter W., Saunders A.M., Roses A.D. ApoE genotype and survival from intracerebral haemorrhage. Lancet. 346:1995;575.
2. Anderson C.M., Swanson R.A. Astrocyte glutamate transport: review of properties, regulation, and physiological functions. Glia. 32:2000;1-14.
3. Ankarcrona M., Dypbukt J.M., Bonfoco E., Zhivotovsky B., Orrenius S., Lipton S.A., Nicotera P. Glutamate-induced neuronal death: a succession of necrosis or apoptosis depending on mitochondrial function. Neuron. 15:1995;961-973.
4. Bennett P.J., Simmonds M.A. The influence of membrane cholesterol on the GABAA receptor. Br. J. Pharmacol. 117:1996;87-92.
5. Bochelen D., Mersel M., Behr P., Lutz P., Kupferberg A. Effect of oxysterol treatment on cholesterol biosynthesis and reactive astrocyte proliferation in injured rat brain cortex. J. Neurochem. 65:1995;2194-2200.
6. Bondarenko A., Chesler M. Rapid astrocyte death induced by transient hypoxia, acidosis, and extracellular ion shifts. Glia. 34:2001;134-142.
7. Bouvier M.M., Mytilineou C. Basic fibroblast growth factor increases division and delays differentiation of dopamine precursors in vitro. J. Neurosci. 15:1995;7141-7149.
8. Brewer G.J., Torricelli J.R., Evege E.K., Price R.J. Optimized survival of hipposcampal neurons in B27-supplemented neurobasal, a new serum-free medium combination. J. Neurosci. Res. 35:1993;567-576.
9. Choi D.W., Rothman S.M. The role of glutamate neurotoxicity in hypoxic-ischemic neuronal death. Annu. Rev. Neurosci. 13:1990;171-182.
10. Choi D.W. Excitotoxic cell death. J. Neurobiol. 23:1992;1261-1276.
11. Choi J.W., Jung S.E. Lovastatin-induced proliferation inhibition and apoptosis in C6 glial cells. J. Pharmacol. Exp. Ther. 289:1999;572-579.
12. Chou Y.-C., Luttge W.G., Sumners C. Characterization of glucocorticoid type II receptors in neuronal and glial cultures from rat brain. J. Neuroendocr. 2:1990;29-38.
13. 3H ]D-aspartate overflow in hippocampal cultures during cyanide-induced ischemia Brain Res. 654:1994;8-14.
14. Chou Y.-C. Corticosterone exacerbates cyanide-induced cell death in hippocampal cultures: role of astrocyte glia. Neurochem. Int. 32:1998;219-226.
15. Cotman C.W., Iversen L.L. Excitatory amino acids in the brain-focus on NMDA receptors. Trends Neurosci. 10:1987;263-265.
16. Crick D.C., Andres D.A., Danesi R., Macchia M., Waechter C.J. Geranylgeraniol overcomes the block of cell proliferation by lovastatin in C6 glioma cells. J. Neurochem. 70:1998;2397-2405.
17. Csernansky J.G., Bardgett M.E., Sheline Y.I., Morris J.C., Olney J.W. CSF excitatory amino acids and severity of illness in Alzheimer's disease. Neurology. 46:1996;1715-1720.
18. Darzynkiewicz Z., Bruno S., Bino G.D., Goreczyca W., Hotz M.A., Lassota P., Traganos F. Features of apoptotic cells measured by flow cytometry. Cytometry. 13:1992;795-808.
19. Dringen R., Pfeiffer B., Hamprecht B. Synthesis of the antioxidant glutathione in neurons: supply by astrocytes of CysGly as precursor for neuronal glutathione. J. Neurosci. 19:1999;562-569.
20. Dubinsky J.M. Intracellular calcium levels during the period of delayed excitotoxicity. J. Neurosci. 13:1993;623-631.
21. Fagan A.M., Murphy B.A., Patel S.N., Kilbridge J.F., Mobley W.C., Bu G., Holtzman D.M. Evidence for normal aging of the septo-hippocampal cholinergic system in apoE (-/-) mice but impaired clearance of axonal degeneration products following injury. Exp. Neurol. 151:1998;314-325.
22. Fassbender K., Simons M., Bergmann C., Stroick M., Lutjohann D., Keller P., Runz H., Kuhl S., Bertsch T., von Bergmann K., Hennerici M., Beyreuther K., Hartmann T. Simvastatin strongly reduces levels of Alzheimer's disease β-amyloid peptides Aβ42 and Aβ40 in vitro and in vivo. Proc. Natl. Acad. Sci. U.S.A. 98:2001;5856-5861.
23. Fiskum G., Murphy A.N., Beal M.F. Mitochondria in neurodegeneration: acute ischemia and chronic neurodegenerative disease. J. Cereb. Blood Flow Metab. 19:1999;351-369.
24. Galbete J.L., Rodriguez-Martin T., Peressini E., Modena P., Bianchi R., Forloni G. Cholesterol decreases secretion of the secreted form of amyloid precursor protein by interfering with glycosylation in the protein secretory pathway. Biochem. J. 348:2000;307-313.
25. Garcia-Roman N., Alvarez A.M., Toro M.J., Montes A., Lorenzo M.J. Lovastatin induces apoptosis of spontaneously immortalized rat brain neuroblasts: involvement of nonsterol isoprenoid biosynthesis inhibition. Mol. Cell. Neurosci. 17:2001;329-341.
26. Gimpl G., Burger K., Fahrenholz F. Cholesterol as modulator of receptor function. Biochemistry. 36:1997;10959-10974.
27. Goodrum J.F., Bouldin T.W., Zhang S.H., Maeda N., Popko B. Nerve regeneration and cholesterol reutilization occur in the absence of apolipoproteins E and A-I in mice. J. Neurochem. 64:1995;408-416.
28. Hamanaka H., Katoh-Fukui Y., Suzuki K., Kobayashi M., Suzuki R., Motegi Y., Nakahara Y., Takeshita A., Kawai M., Ishiguro K., Yokoyama M., Fujita S.C. Altered cholesterol metabolism in human apolipoprotein E4 knock-in mice. Hum. Mol. Gen. 9:2000;353-361.
29. Hamasaki K., Kogure K., Ohwada K. A biological method for the quantitative measurement of tetrodotoxin (TTX): tissue culture bioassay in combination with a water-soluble tetrazolium salt. Toxicon. 34:1996;490-495.
30. Harada J., Sugimoto M. Inhibitors of interleukin-1β-converting enzyme-family proteases (caspases) prevent apoptosis without affecting decreased cellular ability to reduce 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide in cerebellar granule neurons. Brain Res. 793:1998;231-243.
31. Huang Y., von Eckardstein A., Wu S., Assmann G. Effects of the apolipoprotein E polymorphism on uptake and transfer of cell-derived cholesterol in plasma. J. Clin. Invest. 96:1995;2693-2701.
32. Huber G., Matus A. Differences in the cellular distributions of two microtubule-associated proteins, MAP1 and MAP2, in rat brain. J. Neurosci. 4:1984;151-160.
33. Innocenti B., Parpura V., Haydon P.G. Imaging extracellular waves of glutamate during calcium signaling in cultured astrocytes. J. Neurosci. 20:2000;1800-1808.
34. Ishiyama M., Shiga M., Sasamoto K., Mizoguchi M., He P.-G. A new sulfonated tetrazolium salt that produces a highly water-soluble formazan dye. Chem. Pharm. Bull. 41:1993;1118-1122.
35. Jimenez-Jimenez F.J., Molina J.A., Gomez P., Vargas C., de Bustos F., Benito-Leon J., Tallon-Barranco A., Orti-Pareja M., Gasalla T., Arenas J. Neurotransmitter amino acids in cerebrospinal fluid of patients with Alzheimer's disease. J. Neural Transmission. 105:1998;269-277.
36. Jones D.K., Couldwell W.T., Hinton D.R., Su Y., He S., Anker L., Law R.E. Lovastatin induces growth inhibition and apoptosis in human malignant glioma cells. Biochem. Biophys. Res. Commun. 205:1994;1681-1687.
37. Keller P., Simons K. Cholesterol is required for surface transport of influenza virus hemagglutinin. J. Cell Biol. 6:1998;1357-1367.
38. Kim W.T., Rioult M.G., Cornell-Bell A.H. Glutamate-induced calcium signaling in astrocytes. Glia. 11:1994;173-184.
39. Koh J., Choi D.W. Quantitative determination of glutamate mediated cortical neuronal injury in cell culture by lactate dehydrogenase efflux assay. J. Neurosci. Methods. 20:1987;83-90.
40. Kojro E., Gimpl G., Lammich S., Marz W., Fahrenholz F. Low cholesterol stimulates the nonamyloidogenic pathway by its effect on the α-secretase ADAM 10. Proc. Natl. Acad. Sci. U.S.A. 98:2001;5815-5820.
41. Kolena J., Jezova M., Vranova J., Scsukova S. Structure-stabilizing effect of albumin on rat ovarian LH/hCG receptors. Biochim. Biophys. Acta. 1416:1999;208-216.
42. Koudinov A.R., Koudinova N.V. Essential role for cholesterol in synaptic plasticity and neuronal degeneration. FASEB J. 15:2001;1858-1860.
43. Kupferberg A., Teller G., Behr P., Leray C., Urban P.F., Vincendon G., Mersel M. Effect of 7β-hydroxycholesterol on astrocyte primary cultures and derived spontaneously transformed cell lines: cytotoxicity and metabolism. Biochim. Biophys. Acta. 1013:1989;231-238.
44. Kupferberg A., Cremel G., Behr P., van Dorsselaer A., Luu B., Mersel M. Differential sensitivity of astrocyte primary cultures and derived spontaneous transformed cell lines to 7β-hydroxycholesterol: effect on plasma membrane lipid composition and fluidity. and on cell surface protein expression. Mol. Cell. Biochem. 101:1991;11-22.
45. Laskowitz T.Z., Sheng H., Bart R., Joyner K.A., Roses A.D., Warner D.S. Apolipoprotein E deficient mice have increased susceptibility to focal cerebral ischemia. J. Cereb. Blood Flow Metab. 17:1997;753-758.
46. Lee J.-M., Zipfel G.J., Choi D.W. The changing landscape of ischaemic brain injury mechanisms. Nature. 399:1999;A7-A14.
47. Leist D.W., Nicotera P. Apoptosis, excitotoxicity, and neuropathology. Exp. Cell Res. 239:1998;183-201.
48. Liao S.-L., Chen C.-J. Tyrosine kinase signaling involves in glutamate-induced astrocyte proliferation. Neuroreport. 12:2001;3519-3522.
49. Masliah E., Mallory M., Ge N., Alford M., Veinbergs I., Roses A.D. Neurodegeneration in the central nervous system of apoE-deficient mice. Exp. Neurol. 136:1995;107-122.
50. Mason R.P. Probing membrane bilayer interactions of 1,4-dihydropyridine calcium channel blockers. Implications for aging and Alzheimer's disease. Ann. N.Y. Acad. Sci. 747:1994;125-139.
51. Mason R.P., Showmaker W.J., Shajenko L., Chambers T.E., Herbette L.G. Evidence for changes in the Alzheimer disease brain cortical membrane structure mediated by cholesterol. Neurobiol. Aging. 13:1992;413-419.
52. Mauch D.H., Nägler K., Schumacher S., Göritz C., Müller E.-C., Otto A., Pfrieger F.W. CNS synaptogenesis promoted by glia-derived cholesterol. Science. 294:2001;1354-1357.
53. Michikawa M., Yanagisawa K. Inhibition of cholesterol production but not of nonsterol isoprenoid products induces neuronal cell death. J. Neurochem. 72:1999;2278-2285.
54. Michikawa M., Fan Q.-W., Isobe I., Yanagisawa K. Apolipoprotein E exhibits isoform-specific promotion of lipid efflux from astrocytes and neurons in cultures. J. Neurochem. 74:2000;1008-1016.
55. Morita I., Sato I., Ma L., Murota S. Enhancement of membrane fluidity in cholesterol-poor endothelial cells pre-treated with simvastatin. Endothelium. 5:1997;107-113.
56. Nicoll J.A., Roberts G.W., Graham D.I. Apolipoprotein E epsilon 4 allele is associated with deposition of amyloid β-protein following head injury. Nat. Med. 1:1995;135-137.
57. Phillis J.W., Smith-Barbour M., Perkins L.M., O'Regan M.H. Charactrization of glutamate, aspartate, and GABA release from ischemic rat cerebral cortex. Brain Res. Bull. 34:1994;457-466.
58. Poirier J., Baccichet A., Dea D., Gauthier S. Cholesterol synthesis and lipoprotein reuptake during synaptic remodeling in hippocampus in adult rats. Neuroscience. 55:1993;81-90.
59. Porn M.I., Slotte J.P. Localization of cholesterol in sphingomyelinase-treated fibroblasts. Biochem. J. 308:1995;269-274.
60. Raizada M.K., Phillips M.I., Crews F.T., Sumners C. Presence of a unique angiotensin receptor in primary cultures of glial cells from rat brain. Proc. Natl. Acad. Sci. U.S.A. 84:1987;4655-4659.
61. Ransom B.R., Fern R. Does astrocytic glycogen benefit axon function and survival in CNS white matter during glucose deprivation? Glia. 21:1997;134-141.
62. Rao S., Porter D.C., Chen X., Herliczek T., Lowe M., Keyomarsi K. Lovastatin-mediated G1 arrest is through inhibition of the proteasome, independent of hydroxymethyl glutaryl-CoA reductase. Proc. Natl. Acad. Sci. U.S.A. 96:1999;7797-7802.
63. Redjems-Bennani N., Jeandel C., Lefebvre E., Blain H., Vidailhet M., Gueant J.L. Abnormal substrate levels that depend upon mitochondrial function in cerebrospinal fluid from Alzheimer patients. Gerontology. 44:1998;300-304.
64. Schootemeijer A., Gorter G., Tertoolen L.G.J., De Laat S.W., Akkerman J.-W.N. Relation between membrane fluidity and signal transduction in the human megakaryoblastic cell line MEG-01. Biochim. Biophys. Acta. 1236:1995;128-134.
65. Scorziello A., Pellegrini C., Forte L., Tortiglione A., Gioielli A., Iossa S., Amoroso S., Tufano R., Di Renzo G., Annunziato L. Differential vulnerability of cortical and cerebellar neurons in primary culture to oxygen glucose deprivation followed by reoxygenation. J. Neurosci. Res. 63:2001;20-26.
66. Sheng H., Laskowitz D.T., Bennett E., Schmechel D.E., Bart R.D., Saunders A.M., Pearlstein R.D., Roses A.D., Warner D.S. Apolipoprotein E isoform-specific differences in outcome from focal ischemia in transgenic mice. J. Cereb. Blood Flow Metab. 18:1998;361-366.
67. Siman R., Noszek J.C. Excitatory amino acids activate calpain I and induce structural protein breakdown in vivo. Neuron. 1:1988;279-287.
68. Simons M., Keller P., De Strooper B., Beyreuther K., Dotti C.G., Simons K. Cholesterol depletion inhibits the generation of beta-amyloid in hippocampal neurons. Proc. Natl. Acad. Sci. U.S.A. 95:1998;6460-6464.
69. Sochocka E., Juurlink B.H.J., Code W.E., Hertz V., Peng L., Hertz L. Cell death in primary cultures of mouse neurons and astrocytes during exposure to and 'recovery' from hypoxia, substrate deprivation and simulated ischemia. Brain Res. 638:1994;21-28.
70. Song H., Stevens C., Gage F.H. Astroglia induce neurogenesis from adult neural stem cells. Nature. 417:2002;39-44.
71. Steinhauser C., Gallo V. News on glutamate receptors in glial cells. Trends Neurosci. 19:1996;339-345.
72. Stout A.K., Raphael H.M., Kanterewicz B.I., Klann E., Reynolds I.J. Glutamate-induced neuron death requires mitochondrial calcium uptake. Nature Neurosci. 1:1998;366-373.
73. Strittmatter W.J., Saunders A.M., Schmechel D., Pericak-Vance M., Enghlid J., Salvesen G.S., Roses A.D. Apolipoprotein E: high-avidity binding to β-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer's disease. Proc. Natl. Acad. Sci. U.S.A. 90:1993;1977-1981.
74. Svennerholm L., Gottfries C.-G. Membrane lipids, selectively diminished in Alzheimer brains, suggest synapse loss as a primary event in early-onset form (type I) and demyelination in late-onset form (Type II). J. Neurochem. 62:1994;1039-1047.
75. Teasdale G.M., Nicoll J.A., Murray G., Fiddes M. Association of apolipoprotein E polymorphism with outcome after head injury. Lancet. 350:1997;1069-1071.
76. Wu V.W., Schwartz J.P. Cell culture models for reactive gliosis: new perspectives. J. Neurosci. Res. 51:1998;675-681.
77. Wu V.W., Nishiyama N., Schwartz J.P. A culture model of reactive astrocytes: increased nerve growth factor synthesis and reexpression of cytokine responsiveness. J. Neurochem. 71:1998;749-756.
78. Yamauchi K., Tozuka M., Nakabayashi T., Sugano M., Hidaka H., Kondo Y., Katsuyama T. Apolipoprotein E in cerebrospinal fluid: relation to phenotype and plasma apolipoprotein E concentrations. Clin. Chem. 45:1999;497-504.